GLP-1 RAs and Dietary Intake and Body Composition
Longitudinal Effects of GLP-1 Receptor Agonists on Dietary Intake and Body Composition
To assess longitudinal changes in dietary intake, body composition and metabolism with GLP-1 RA use.
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Undersøgelsestype
Undersøgelsestype
Tilmelding (Anslået)
Tilmelding
Kontakter og lokationer
Studiesteder
-
-
Ohio
-
Athens, Ohio, Forenede Stater, 45701
- Rekruttering
- Exercise Physiology Lab
-
Kontakt:
- Angela Hillman, PhD
- Telefonnummer: 740-593-0153
- E-mail: hillman@ohio.edu
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
People taking GLP-1 RA medications
Beskrivelse
Inclusion Criteria:
- Currently taking GLP-1 medications and have been taking them for less than a month
- between the ages of 18-75 years
Exclusion Criteria:
- Not between the ages of 18-75 years
- Not currently using GLP-1 medications
- Have been using GLP-1 medications for 1 month or longer
- Currently pregnant
- Currently nursing
- Bariatric surgery in the last 3 months
- Have an implanted cardiac device, such as a pacemaker or defibrillator
- Not willing to have a DEXA (full body x-ray) at the start and end of the 12 week study period
- Not willing to have a bioelectrical impedance body composition scan at the start and every 2 weeks during the 12 week study period
- Not willing to have your resting metabolism measured at the start and end of the 12 week study period
- Not willing to track your diet at the beginning and end of the study
- Not willing to complete surveys assessing depression, food noise and disordered eating
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Observationsmodeller: COHORT
- Tidsperspektiver: PROSPECTIVE
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
change in body mass
Tidsramme: 12 weeks
|
change in body weight measured in kg using BIA and DEXA |
12 weeks
|
|
change in skeletal muscle mass
Tidsramme: 12 weeks
|
change in skeletal muscle mass measured in kg using BIA and DEXA |
12 weeks
|
|
change in body fat mass
Tidsramme: 12 weeks
|
change in body fat mass measured in kg using BIA and DEXA |
12 weeks
|
|
change in resting metabolism
Tidsramme: 12 weeks
|
change in resting metabolic rate in kcals/day as measured via indirect calorimetry |
12 weeks
|
|
change in substrate utilization rates
Tidsramme: 12 weeks
|
change in resting carbohydrate and fat oxidation rates as measured via indirect calorimetry |
12 weeks
|
|
change in bone mineral content
Tidsramme: 12 weeks
|
change in bone mineral content measured via DEXA and BIA |
12 weeks
|
|
change in bone mineral density
Tidsramme: 12 weeks
|
change in bone mineral density measured via DEXA |
12 weeks
|
|
change in total daily caloric intake
Tidsramme: 12 weeks
|
change in total daily caloric intake measured via 24 hour food diary |
12 weeks
|
|
change in daily carbohydrate intake
Tidsramme: 12 weeks
|
change in daily carbohydrate intake measured via 24 hour food diary |
12 weeks
|
|
change in daily fat intake
Tidsramme: 12 weeks
|
change in daily fat intake measured via 24 hour food diary |
12 weeks
|
|
change in daily protein intake
Tidsramme: 12 weeks
|
change in daily protein intake measured via 24 hour food diary |
12 weeks
|
|
change in daily mineral intake
Tidsramme: 12 weeks
|
change in daily mineral intake measured via 24 hour food diary |
12 weeks
|
|
change in daily vitamin intake
Tidsramme: 12 weeks
|
change in daily vitamin intake measured via 24 hour food diary |
12 weeks
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Studiestart
Primær færdiggørelse (Anslået)
Primær færdiggørelse
Studieafslutning (Anslået)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- IRB-FY26-568
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .